PL3579888T3 - Kompozycje wytwarzające elektrochemiczny transmiter oraz sposoby ich stosowania oraz opatrunki i układy leczenia, w których się je stosuje - Google Patents
Kompozycje wytwarzające elektrochemiczny transmiter oraz sposoby ich stosowania oraz opatrunki i układy leczenia, w których się je stosujeInfo
- Publication number
- PL3579888T3 PL3579888T3 PL18751918.6T PL18751918T PL3579888T3 PL 3579888 T3 PL3579888 T3 PL 3579888T3 PL 18751918 T PL18751918 T PL 18751918T PL 3579888 T3 PL3579888 T3 PL 3579888T3
- Authority
- PL
- Poland
- Prior art keywords
- same
- dressings
- electrochemical
- methods
- treatment systems
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/01—Non-adhesive bandages or dressings
- A61F13/01008—Non-adhesive bandages or dressings characterised by the material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/00051—Accessories for dressings
- A61F13/00063—Accessories for dressings comprising medicaments or additives, e.g. odor control, PH control, debriding, antimicrobic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0009—Galenical forms characterised by the drug release technique; Application systems commanded by energy involving or responsive to electricity, magnetism or acoustic waves; Galenical aspects of sonophoresis, iontophoresis, electroporation or electroosmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/44—Medicaments
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/10—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing inorganic materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/10—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing inorganic materials
- A61L2300/102—Metals or metal compounds, e.g. salts such as bicarbonates, carbonates, oxides, zeolites, silicates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/10—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing inorganic materials
- A61L2300/114—Nitric oxide, i.e. NO
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/412—Tissue-regenerating or healing or proliferative agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
- A61L2300/602—Type of release, e.g. controlled, sustained, slow
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/80—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special chemical form
- A61L2300/802—Additives, excipients, e.g. cyclodextrins, fatty acids, surfactants
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01B—NON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
- C01B17/00—Sulfur; Compounds thereof
- C01B17/48—Sulfur dioxide; Sulfurous acid
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01B—NON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
- C01B21/00—Nitrogen; Compounds thereof
- C01B21/20—Nitrogen oxides; Oxyacids of nitrogen; Salts thereof
- C01B21/50—Nitrous acid; Salts thereof
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Vascular Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Dermatology (AREA)
- Communicable Diseases (AREA)
- Virology (AREA)
- Oncology (AREA)
- Hematology (AREA)
- Materials Engineering (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Media Introduction/Drainage Providing Device (AREA)
- Materials For Medical Uses (AREA)
- Cosmetics (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762457039P | 2017-02-09 | 2017-02-09 | |
| PCT/US2018/014265 WO2018147986A1 (en) | 2017-02-09 | 2018-01-18 | Electrochemical gasotransmitter generating compositions and methods of using same and dressings and treatment systems incorporating same |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3579888T3 true PL3579888T3 (pl) | 2024-05-27 |
Family
ID=63038868
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL18751918.6T PL3579888T3 (pl) | 2017-02-09 | 2018-01-18 | Kompozycje wytwarzające elektrochemiczny transmiter oraz sposoby ich stosowania oraz opatrunki i układy leczenia, w których się je stosuje |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US10342706B2 (pl) |
| EP (1) | EP3579888B1 (pl) |
| JP (1) | JP6989157B2 (pl) |
| KR (1) | KR102189597B1 (pl) |
| CN (1) | CN110461374B (pl) |
| AU (1) | AU2018218200B2 (pl) |
| CA (1) | CA3053141A1 (pl) |
| CL (1) | CL2019002220A1 (pl) |
| ES (1) | ES2965705T3 (pl) |
| IL (1) | IL268577B (pl) |
| MX (1) | MX389787B (pl) |
| PL (1) | PL3579888T3 (pl) |
| WO (1) | WO2018147986A1 (pl) |
| ZA (1) | ZA201905431B (pl) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20190328774A1 (en) * | 2017-02-09 | 2019-10-31 | Noxsano Inc. | Electrochemical gasotransmitter generating compositions and methods of using same and dressings and treatment systems incorporating same |
| CN112351758B (zh) * | 2018-04-25 | 2023-03-10 | 诺克斯萨诺股份有限公司 | 生成光活化气体递质的组合物 |
| JP7396598B2 (ja) * | 2018-06-08 | 2023-12-12 | 住友精化株式会社 | 皮膚創傷用組成物 |
| KR20210019434A (ko) | 2018-06-08 | 2021-02-22 | 스미토모 세이카 가부시키가이샤 | 염증성 소화 기관 질환용 조성물 |
| KR20210116506A (ko) * | 2019-01-11 | 2021-09-27 | 녹사노 아이엔씨. | 전기화학적 기체 신호 전달물질 발생 조성물 및 기체 신호 전달물질 발생을 위한 바이메탈 셀 |
| TWI694844B (zh) * | 2019-01-29 | 2020-06-01 | 明基材料股份有限公司 | 硫化氫緩釋敷料及其製造方法 |
| CN109793919B (zh) * | 2019-02-01 | 2022-01-14 | 明基材料(芜湖)有限公司 | 硫化氢缓释敷料及其制造方法 |
| BR112021023832A8 (pt) * | 2019-06-04 | 2023-02-28 | Thirty Holdings Ltd | Métodos e composições para geração de óxido nítrico e usos dos mesmos |
| GB2599818B (en) * | 2019-06-04 | 2024-01-31 | Thirty Respiratory Ltd | Methods and compositions for generating nitric oxide and uses thereof to deliver nitric oxide via the respiratory tract |
| US20230087246A1 (en) * | 2020-01-30 | 2023-03-23 | 3M Innovative Properties Company | Delivery system for aqueous zinc oral care compositions with fluoride |
| CN115382095B (zh) * | 2022-08-21 | 2025-08-08 | 兰州理工大学 | 超级电容器、应用超级电容器的伤口敷料,以及制备方法 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5797887A (en) * | 1996-08-27 | 1998-08-25 | Novovasc Llc | Medical device with a surface adapted for exposure to a blood stream which is coated with a polymer containing a nitrosyl-containing organo-metallic compound which releases nitric oxide from the coating to mediate platelet aggregation |
| US5994444A (en) * | 1997-10-16 | 1999-11-30 | Medtronic, Inc. | Polymeric material that releases nitric oxide |
| US6103275A (en) * | 1998-06-10 | 2000-08-15 | Nitric Oxide Solutions | Systems and methods for topical treatment with nitric oxide |
| US20090036516A1 (en) * | 2003-01-13 | 2009-02-05 | Ctg Pharma S.R.L. | Compounds for treating metabolic syndrome |
| MX2009003741A (es) * | 2006-10-05 | 2009-07-10 | Ikaria Inc | Composiciones liquidas de calcogenuro y metodos para fabricar y utilizar las mismas. |
| EP2300603A4 (en) * | 2008-06-24 | 2011-08-03 | Micropharma Ltd | OXIDE DEVICE AND METHOD FOR WOUND HEALING, TREATMENT OF SKIN DISEASES AND MICROBIAL INFECTIONS |
| EP2519297A4 (en) * | 2009-12-31 | 2013-08-21 | Univ Ohio | SYSTEMS AND METHOD FOR PROMOTING WOUND HEALING |
| US8771755B2 (en) | 2011-09-14 | 2014-07-08 | Nuevas Alternativas Naturales, S.A.P.I. de C.V. | Preparation and compositions of highly bioavailable zerovalent sulfur and uses thereof |
| US9561134B2 (en) * | 2011-09-14 | 2017-02-07 | Matthew T. Scholz | Positive pressure medical dressings with valve and kits containing same |
| US9480785B2 (en) | 2012-03-30 | 2016-11-01 | The Regents Of The University Of Michigan | Nitric oxide delivery devices |
| US9498571B2 (en) * | 2012-03-30 | 2016-11-22 | The Regents Of The University Of Michigan | Nitric oxide delivery devices |
| BR102013022095A2 (pt) | 2013-08-29 | 2016-08-02 | Mineração Tabiporã Ltda | processo para a obtenção de sulfeto de hidrogênio a partir da redução de sulfato de cálcio e da decomposição do sulfeto de cálcio com cloreto de magnésio |
| AU2014345526B2 (en) * | 2013-11-07 | 2018-03-15 | Bsn Medical Gmbh | Medical dressing |
-
2018
- 2018-01-18 JP JP2019565149A patent/JP6989157B2/ja active Active
- 2018-01-18 US US15/874,665 patent/US10342706B2/en active Active
- 2018-01-18 KR KR1020197026047A patent/KR102189597B1/ko active Active
- 2018-01-18 ES ES18751918T patent/ES2965705T3/es active Active
- 2018-01-18 CN CN201880022253.5A patent/CN110461374B/zh active Active
- 2018-01-18 WO PCT/US2018/014265 patent/WO2018147986A1/en not_active Ceased
- 2018-01-18 PL PL18751918.6T patent/PL3579888T3/pl unknown
- 2018-01-18 MX MX2019009384A patent/MX389787B/es unknown
- 2018-01-18 AU AU2018218200A patent/AU2018218200B2/en active Active
- 2018-01-18 EP EP18751918.6A patent/EP3579888B1/en active Active
- 2018-01-18 CA CA3053141A patent/CA3053141A1/en active Pending
-
2019
- 2019-08-07 IL IL268577A patent/IL268577B/en active IP Right Grant
- 2019-08-07 CL CL2019002220A patent/CL2019002220A1/es unknown
- 2019-08-16 ZA ZA2019/05431A patent/ZA201905431B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| BR112019016486A2 (pt) | 2020-04-07 |
| AU2018218200B2 (en) | 2023-11-23 |
| EP3579888A1 (en) | 2019-12-18 |
| KR102189597B1 (ko) | 2020-12-14 |
| ES2965705T3 (es) | 2024-04-16 |
| CL2019002220A1 (es) | 2020-01-03 |
| EP3579888B1 (en) | 2023-09-27 |
| US10342706B2 (en) | 2019-07-09 |
| AU2018218200A1 (en) | 2019-08-29 |
| ZA201905431B (en) | 2020-05-27 |
| KR20190108169A (ko) | 2019-09-23 |
| JP6989157B2 (ja) | 2022-01-05 |
| MX389787B (es) | 2025-03-19 |
| US20180221210A1 (en) | 2018-08-09 |
| IL268577B (en) | 2020-03-31 |
| CN110461374A (zh) | 2019-11-15 |
| CA3053141A1 (en) | 2018-08-16 |
| CN110461374B (zh) | 2022-05-31 |
| EP3579888C0 (en) | 2023-09-27 |
| JP2020511526A (ja) | 2020-04-16 |
| WO2018147986A1 (en) | 2018-08-16 |
| MX2019009384A (es) | 2019-12-11 |
| IL268577A (en) | 2019-09-26 |
| EP3579888A4 (en) | 2021-04-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA201905431B (en) | Electrochemical gasotransmitter generating compositions and methods of using same and dressings and treatment systems incorporating same | |
| IL274276A (en) | CASZ preparations and methods of use | |
| GB2582100B (en) | CAS12C Compositions and methods of use | |
| EP3310395A4 (en) | REGULATION OF RNA GUIDED TRANSCRIPTION AND METHODS OF USE THEREOF FOR THE TREATMENT OF LOMBALGIA | |
| SG11202004680UA (en) | Cellular compositions and methods of treatment i | |
| IL274635A (en) | Stable ascorbic acid preparations and methods of using them | |
| ZA201906169B (en) | Synthekine compositions and methods of use | |
| IL275182A (en) | Preparations and methods for the treatment of metabolic conditions | |
| PH12018501279A1 (en) | Compositions comprising 15-hepe and methods of using the same | |
| ZA202000502B (en) | Cosmetic compositions and methods of use | |
| EP3247364A4 (en) | Compositions and methods of treating microbes | |
| EP3258908A4 (en) | Compositions and methods for treatment of skin infections | |
| SG11201705524SA (en) | Compositions and methods for the treatment of inflammation and pain | |
| GB201511799D0 (en) | Composition and methods of treatment | |
| IL274563A (en) | Methods of use and preparations containing dolaglutide | |
| IL273151A (en) | Power systems and power supply methods through them | |
| SG11202000612TA (en) | Methods and compositions for the treatment of melanoma | |
| GB201621737D0 (en) | Compositions and methods of treatment | |
| EP3256094A4 (en) | Dental compositions and methods of use | |
| GB201605127D0 (en) | Composition and methods of treatment | |
| GB201710491D0 (en) | Composition and methods of treatment | |
| HK40035998A (en) | Cellular compositions and methods of treatment i | |
| ZA202004110B (en) | Compositions and methods for the treatment of metabolic conditions | |
| HK40034329A (en) | Compositions and methods for the treatment of allergy | |
| GB201810925D0 (en) | Compositions and methods of treatment |